InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 12/14/2013

Re: None

Monday, 01/13/2014 9:48:15 AM

Monday, January 13, 2014 9:48:15 AM

Post# of 30384
OMG!! Pascoe is on the BODs of KenPharm-- no wonder he doesn't give Femprox or Vitaros presentations hes out working and trying to make stock and money elswhere!!
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the appointment of Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel, Stine Seed Company, to the company's Board of Directors. The additions of Mr. Pascoe and Mr. Saluri bring extensive public company and business development experience to KemPharm as the company prepares for multiple clinical and business milestones in 2014, including the expected submission of a New Drug Application (NDA) for KP201, KemPharm's lead clinical candidate, in the third quarter of 2014.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News